The present invention disclosed compounds of Formula I. The present invention also discloses beta-3 agonists of formula I and methods for treating beta-3 mediated diseases and condition using the compounds of formula I, in particular methods for treating diabetes or obesity.
David Edward Uehling - Durham NC, US Robert Dale Hubbard - Durham NC, US Alex Gregory Waterson - Durham NC, US Kimberly Petrov - Durham NC, US Neil Bifulco, Jr. - Durham NC, US Joseph Wendell Wilson - Durham NC, US Jennifer Gabriel Badiang - Durham NC, US Mul Cheung - Collegeville PA, US Mariko Yamabe - Tokyo, JP
Assignee:
GlaxoSmithKline LLC - Philadelphia PA
International Classification:
C07D 471/04 A61K 31/437
US Classification:
5142358, 51425214, 514275, 544122, 544295, 544331
Abstract:
The present invention provides 2-pyrimidinyl pyrazolopyridine compounds, compositions containing the same, as well as processes for the preparation and their use as pharmaceutical agents.
David Edward Uehling - Durham NC, US Kirk Lawrence Stevens - Durham NC, US Scott Howard Dickerson - Durham NC, US Alex Gregory Waterson - Durham NC, US Philip Anthony Harris - Durham NC, US Douglas McCord Sammond - Durham NC, US Robert Dale Hubbard - Lindenhurst IL, US Holly Kathleen Emerson - Durham NC, US Joseph W. Wilson - Durham NC, US
Assignee:
GlaxoSmithKline LLC - Philadelphia PA
International Classification:
C07D 471/04 A61K 31/437
US Classification:
5142358, 51425214, 514275, 544122, 544295, 544331
Abstract:
The present invention provides 2-pyrimidinyl pyrazolopyridine compounds, compositions containing the same, as well as processes for the preparation and their use as pharmaceutical agents.
Kevin Kuntz - Durham NC, US David Edward Uehling - Durham NC, US Alex Gregory Waterson - Durham NC, US Kyle Allen Emmitte - Durham NC, US Kirk Stevens - Durham NC, US John Brad Shotwell - Durham NC, US Stephon Cornell Smith - Durham NC, US Kristen E. Nailor - Durham NC, US James M. Salovich - Durham NC, US Brian John Wilson - Durham NC, US Mui Cheung - King of Prussia PA, US Robert Anthony Mook - Durham NC, US Erich W. Baum - Durham NC, US Ganesh Moorthy - Collegeville PA, US
The present invention provides imidazopyridine compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.
Benzene Sulfonamide Thiazole And Oxazole Compounds
George Adjabeng - Durham NC, US Jerry Leroy Adams - Collegeville PA, US Scott Howard Dickerson - Durham NC, US Keith Hornberger - Mount Sinai NY, US Neil W. Johnson - Collegeville PA, US Kevin Kuntz - Durham NC, US Kimberly Petrov - Durham NC, US Jeffrey M. Ralph - Collegeville PA, US Tara Renae Rheault - Durham NC, US Gregory Schaaf - Durham NC, US John Stellwagen - Durham NC, US Xinrong Tian - Collegeville PA, US David E. Uehling - Durham NC, US Alex G. Waterson - Durham NC, US Brian Wilson - Durham NC, US
The present invention provides thiazole sulfonamide and oxazole sulfonamide compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.
Thienopyrimidine Compounds As Protein Tyrosine Kinase Inhibitors
Thomas Caferro - Durham NC, US Stanley Chamberlain - Durham NC, US Kelly Donaldson - Durham NC, US Philip Harris - Durham NC, US Michael Gaul - Yardley PA, US David Uehling - Durham NC, US Dana Vanderwall - Durham NC, US
International Classification:
A61K031/519 C07D498/02
US Classification:
514260100, 544279000
Abstract:
The present invention relates to thienopyrmidine compounds of formula (I) (one of Aand Ais S and the other is CH), salts thereof, as well as use and preparation of the same. These compounds are inhibitors of various protein tyrosine kinases (PTKs) of the ErbB family and consequently are useful in the treatment of disorders mediated by aberrant activity of such kinases.
David Deaton - Durham NC, US Barry Shearer - Durham NC, US David Uehling - Durham NC, US
International Classification:
A61K 31/381 A61K 31/34
US Classification:
514448000, 514471000
Abstract:
The present invention discloses compounds of Formula I. The present invention also discloses beta-3 agonists of formula I and methods for treating beta-3 mediated diseases and condition using the compounds of formula I, in particular methods for treating diabetes or obesity.
Benzene Sulfonamide Thiazole And Oxazole Compounds
Jerry Leroy Adams - Collegeville PA, US Scott Howard Dickerson - Durham NC, US Neil W. Johnson - Collegeville PA, US Kevin Kuntz - Durham NC, US Kimberly Petrov - Durham NC, US Jeffrey M. Ralph - Collegeville PA, US Tara Renae Rheault - Durham NC, US Gregory Schaaf - Durham NC, US John Stellwagen - Durham NC, US Xinrong Tian - Collegeville PA, US David Edward Uehling - Durham NC, US Alex Gregory Waterson - Durham NC, US Brian Wilson - Durham NC, US
The present invention provides thiazole sulfonamide and oxazole sulfonamide compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.